Pope Michael Ross - 23 Feb 2022 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role
Director
Signature
/s/ Christopher David, as Attorney-in-Fact for Michael Pope
Issuer symbol
NVOS
Transactions as of
23 Feb 2022
Net transactions value
$0
Form type
4
Filing time
24 Feb 2022, 15:05:22 UTC
Previous filing
24 Feb 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVOS Stock option(right to buy) Award $0 +93,995 $0.000000 93,995 23 Feb 2022 Common Stock 93,995 $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant approved by the issuer's Board of Directors. The stock option vests, and becomes exercisable, with respect to 7,833 shares each month, beginning on the date of grant, until December 23, 2022 and with respect to 7,832 shares on January 23, 2023.